The most common GLP-1 side effects are headaches, nausea, and gastrointestinal issues
Dopamine inhibits thyrotropin-releasing hormone release from rat adrenal gland in vitro
However, GLP-1RAs are usually modified analogues that are designed to be much longer acting, with a therapeutic window of up to 1 week, and their use is rapidly becoming a key treatment for patients with type 2 diabetes as well as those with a requirement for weight loss
Studies in models of Parkinsons disease suggest these medications may decrease inflammation, enhance cellular energy production, and improve the function of critical brain cells associated with movement all processes that are known to be impacted by Parkinsons
PlexusDx patients who achieve sustainable weight reduction often report improved energy and metabolism, though these changes should be monitored with routine thyroid blood work
If you are unsure where to start, we offer a Health Quiz designed to help you identify which areas of your wellness routine might need the most support